Symptomatic venous thromboembolism after total knee replacement

被引:54
|
作者
Warwick, DJ [1 ]
Whitehouse, S [1 ]
机构
[1] BRISTOL KNEE GRP, BRISTOL, AVON, ENGLAND
来源
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | 1997年 / 79B卷 / 05期
关键词
D O I
10.1302/0301-620X.79B5.7761
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Chemical prophylaxis is known to reduce the venographic prevalence of deep-vein thrombosis (DVT) after total knee replacement (TKR), but it is uncertain whether this affects the incidence of symptoms. Further analysis depends ion the basic epidemiology of thromboembolic symptoms, We therefore studied the pattern of such symptoms in a consecutive series of 1000 patients with primary TMR, with particular reference to risk factors and prophylaxis. We reviewed all the clinical records and contacted all the patients individually, noting risk factors, prophylaxis, symptomatic pulmonary embolus (PE) or DVT and its timing, death and its causes, and all complications, All the patients wore antiembolism stockings, 83% had regional anaesthesia and 33.9% had chemical prophylaxis. One patient died from PE on the day of surgery, having had no prophylaxis giving a rate of 0.1% (95% CI 0.003% to 0.56%). Symptomatic, radiologically confirmed thromboembolism (VTE) tvas common with a rate of 10.6% (95% CI 8.7% to 12.5%). There was a similar incidence of VTE in those with and without chemical prophylaxis (10.1% v 10.5%, RR 0.96, NS). VTE was more common in patients with risk factors (15.1% v 9.5%, RR 1.59, p = 0.02) and tended to occur earlier in this group (median day of onset 5 v 7, p = 0.01). Chemical prophylaxis did not reduce the frequency of symptomatic thromboembolism in either those with risk factors (RR 0.81, p = 0.5) or those without them (RR 0.94, p = 0.8). Haematoma or wound dehiscence was more common in those having chemical prophylaxis (11.9% v 6.9%; RR 1.73 95% CI 1.16 to 2.60). Readmission for symptomatic, radio-logically confirmed thromboembolism involved 1.1% of patients (95% CI 0.55% to 2.1%). Four patients were readmitted with proven non-fatal PE and six with proven DVT (the latest on day 40). Our results show that the main risk factor for thromboembolism was TKR itself; chemical prophylaxis did not reduce the incidence of symptomatic-thromboembolism but gave an increased perception of side-effects. Near prophylaxis methods or combinations of methods are needed, with their efficacy compared by randomised controlled studies of both the clinical and the radiological effect.
引用
收藏
页码:780 / 786
页数:7
相关论文
共 50 条
  • [31] Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review
    Rashki Kemmak, Asma
    Abutorabi, Ali
    Alipour, Vahid
    CLINICAL DRUG INVESTIGATION, 2020, 40 (08) : 715 - 725
  • [33] PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP AND KNEE ARTHROPLASTY
    LIEBERMAN, JR
    GEERTS, WH
    JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1994, 76A (08): : 1239 - 1250
  • [34] RivaroxabanA Review of its Use for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement Surgery
    Sean T. Duggan
    Lesley J. Scott
    Greg L. Plosker
    Drugs, 2009, 69 : 1829 - 1851
  • [35] Rivaroxaban A Review of its Use for the Prophylaxis of Venous Thromboembolism after Total Hip or Knee Replacement Surgery
    Duggan, Sean T.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (01) : 57 - 72
  • [36] COST-EFFECTIVENESS OF APIXABAN AND ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT IN CHINA
    Yan, X. Y.
    Gu, X. H.
    Bu, J.
    Lin, H. W.
    Wu, B.
    VALUE IN HEALTH, 2016, 19 (07) : A651 - A651
  • [37] RivaroxabanA Review of its Use for the Prophylaxis of Venous Thromboembolism after Total Hip or Knee Replacement Surgery
    Sean T. Duggan
    American Journal of Cardiovascular Drugs, 2012, 12 : 57 - 72
  • [38] Rivaroxaban A Review of its Use for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement Surgery
    Duggan, Sean T.
    Scott, Lesley J.
    Plosker, Greg L.
    DRUGS, 2009, 69 (13) : 1829 - 1851
  • [39] Economic Evaluation of Dabigatran Etexilate for the Prevention of Venous Thromboembolism After Total Knee and Hip Replacement Surgery
    Wolowacz, Sorrel E.
    Roskell, Neil S.
    Maciver, Fiona
    Beard, Stephen M.
    Robinson, Paul A.
    Plumb, Jonathan M.
    Dolan, Gerry
    Brenkel, Ivan J.
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 194 - 212
  • [40] Predictive blood coagulation markers for early diagnosis of venous thromboembolism after total knee joint replacement
    Watanabe, Hideaki
    Madoiwa, Seiji
    Sekiya, Hitoshi
    Nagahama, Yutaka
    Matsuura, Shirou
    Kariya, Yusei
    Ohmori, Tsukasa
    Mimuro, Jun
    Hoshino, Yuichi
    Hayasaka, Shinya
    Sakata, Yoichi
    THROMBOSIS RESEARCH, 2011, 128 (06) : E137 - E143